BindingDB logo
myBDB logout

BDBM50463840 CHEMBL4239361

SMILES: NC(=O)c1cnc2[nH]ccc2c1NC12CC3CC(CC(C3)C1)C2

InChI Key: InChIKey=XUWWTDITFKFAPU-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50463840   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50463840
PNG
(CHEMBL4239361)
Show SMILES NC(=O)c1cnc2[nH]ccc2c1NC12CC3CC(CC(C3)C1)C2 |THB:18:17:14:20.19.21,18:19:16.17.22:14,21:19:16:22.13.14,21:13:16:20.18.19,12:13:16:20.18.19|
Show InChI InChI=1S/C18H22N4O/c19-16(23)14-9-21-17-13(1-2-20-17)15(14)22-18-6-10-3-11(7-18)5-12(4-10)8-18/h1-2,9-12H,3-8H2,(H2,19,23)(H2,20,21,22)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 120n/an/an/an/an/an/a



Astellas Pharma Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human N-terminal His-tagged JAK2 catalytic domain (826 to 1132 residues) expressed in baculovirus expression system using B...


Bioorg Med Chem 26: 4971-4983 (2018)


Article DOI: 10.1016/j.bmc.2018.08.005
BindingDB Entry DOI: 10.7270/Q2Z89G3M
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50463840
PNG
(CHEMBL4239361)
Show SMILES NC(=O)c1cnc2[nH]ccc2c1NC12CC3CC(CC(C3)C1)C2 |THB:18:17:14:20.19.21,18:19:16.17.22:14,21:19:16:22.13.14,21:13:16:20.18.19,12:13:16:20.18.19|
Show InChI InChI=1S/C18H22N4O/c19-16(23)14-9-21-17-13(1-2-20-17)15(14)22-18-6-10-3-11(7-18)5-12(4-10)8-18/h1-2,9-12H,3-8H2,(H2,19,23)(H2,20,21,22)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 110n/an/an/an/an/an/a



Astellas Pharma Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human N-terminal GST-tagged JAK1 catalytic domain (850 to 1154 residues) expressed in baculovirus expression system using B...


Bioorg Med Chem 26: 4971-4983 (2018)


Article DOI: 10.1016/j.bmc.2018.08.005
BindingDB Entry DOI: 10.7270/Q2Z89G3M
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM50463840
PNG
(CHEMBL4239361)
Show SMILES NC(=O)c1cnc2[nH]ccc2c1NC12CC3CC(CC(C3)C1)C2 |THB:18:17:14:20.19.21,18:19:16.17.22:14,21:19:16:22.13.14,21:13:16:20.18.19,12:13:16:20.18.19|
Show InChI InChI=1S/C18H22N4O/c19-16(23)14-9-21-17-13(1-2-20-17)15(14)22-18-6-10-3-11(7-18)5-12(4-10)8-18/h1-2,9-12H,3-8H2,(H2,19,23)(H2,20,21,22)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 10n/an/an/an/an/an/a



Astellas Pharma Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human N-terminal His-tagged JAK3 catalytic domain (795 to 1124 residues) expressed in baculovirus expression system using B...


Bioorg Med Chem 26: 4971-4983 (2018)


Article DOI: 10.1016/j.bmc.2018.08.005
BindingDB Entry DOI: 10.7270/Q2Z89G3M
More data for this
Ligand-Target Pair